Curriculum

P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025

Pri-Med's P.A.C.T. program empowers you with the skills to effectively diagnose, treat, and manage pain holistically, highlighting both opioid and nonopioid pharmacologic interventions.

Loading... Begin

CME Information

Up to 6.50 AMA PRA Category 1 Credits™, 6.50 ABIM MOC or 6.64 AANP, 2.90 AANP Pharm

Release Date: 11/1/2024

Available for credit until 10/31/2025

Topics

Faculty

Learning Objectives

  • Discuss the definitions and mechanisms of pain
  • Identify risk factors and stratification for opioid-related aberrant behavior and opioid use disorder as part of the initial assessment
  • Apply individualized recommendations for nonpharmacologic and non-opioid treatment options for patients in pain
  • Review general characteristics of opioid analgesics including their intended use and risks
  • Differentiate among tolerance, physical dependence, and manifestations of opioid use disorder
  • Recognize best practices to reduce the risks associated with prescription of opioid analgesics, including safe storage and disposal
  • Anticipate and manage adverse effects of opioid use including signs of opioid overdose and the use of naloxone
  • Select approaches to safely initiate opioids for the treatment of acute pain and chronic pain
  • Identify strategies for ongoing safe and effective use of opioids in patients with chronic pain, including titration, referral, and discontinuation, when appropriate
  • Summarize counseling strategies for caregivers and patients on opioid therapy
  • Act appropriately to evaluate, treat, or refer patients with opioid use disorder
     

Core Curriculum

P.A.C.T. offers a Core Curriculum aligned with the REMS FDA Blueprint, available as an on-demand webcast or 3-part interactive series. Learners are also encouraged to participate in Reinforcement activities.

Completing the Core Curriculum and Reinforcement courses earns learners up to 6.5 CME credits, towards meeting MATE Act requirements and providing comprehensive education on opioid analgesic safety and efficacy to fulfill regulatory and state standards.

Path 1: On-Demand Webcast

4.00 CME/CE CREDITS

1 Course

Path 2: Interactive Learning

4.00 CME/CE CREDITS

3 Courses

Reinforcement Courses

2.50 CME/CE CREDITS
5 Courses

Faculty

Charles E. Argoff, MD, FABPM

Vice Chair, Albany Medical College, Professor of Neurology and Urology

Read More
Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, School of Medicine and Biomedical Sciences, University of Buffalo School of Medicine

Read More
Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chairperson, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Read More
Aubrey J. Grant, MD, FACC

Founder and CEO, Equity Commons

Read More

Supported by

Opioid Analgesic REMS Program Companies 

Education Partner

Miller Medical Communications, LLC 

Fine Print

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.